-
Venn, NC, Huang, L, Hovorková, L, Muskovic, W, Wong, M, Law, T, Heatley, SL, Khaw, SL, Revesz, T, Dalla Pozza, L, et al.
Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions..
Br J Cancer
127(5)
:
908 -915
2022
view publication
-
Rives, S, Maude, SL, Hiramatsu, H, Baruchel, A, Bader, P, Bittencourt, H, Buechner, J, Laetsch, T, De Moerloose, B, Qayed, M, et al.
S112: TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B‐CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B‐ALL): FINAL ANALYSES FROM THE ELIANA STUDY.
HemaSphere
6:
13 -14
2022
view publication
-
Minard‐Colin, V, Buechner, J, Locatelli, F, Martinez, BG, Vormoor, BJ, Cooper, S, Krueger, J, Napolitano, S, Attarbaschi, A, Baruchel, A, et al.
S255: EFFICACY AND SAFETY OF TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) MATURE B‐CELL NON‐HODGKIN LYMPHOMA (NHL): THE PHASE II BIANCA STUDY.
HemaSphere
6:
156 -157
2022
view publication
-
Brown, LM, Hediyeh-Zadeh, S, Sadras, T, Huckstep, H, Sandow, JJ, Bartolo, RC, Kosasih, HJ, Davidson, NM, Schmidt, B, Bjelosevic, S, et al.
SFPQ-ABL1 and BCR-ABL1 use different signaling networks to drive B-cell acute lymphoblastic leukemia..
Blood Adv
6(7)
:
2373 -2387
2022
view publication
-
McClure, BJ, Pal, M, Heatley, SL, Rehn, J, Schutz, C, Breen, J, Venn, NC, Sutton, R, Khaw, SL, Yeung, DT, et al.
Two novel cases of NUTM1-rearranged B-cell acute lymphoblastic leukaemia presenting with high-risk features..
Br J Haematol
196(6)
:
1407 -1411
2022
view publication